Literature DB >> 23475069

Vascular growth factors in neuropsychiatry.

Samuel S Newton1, Neil M Fournier, Ronald S Duman.   

Abstract

Recent advances in understanding the cellular and molecular basis of psychiatric illnesses have shed light on the important role played by trophic factors in modulating functional parameters associated with disease causality and drug action. Disease mechanisms are now thought to involve multiple cell types, including neurons and endothelial cells. These functionally distinct but interactively coupled cell types engage in cellular cross talk via shared and common signaling molecules. Dysregulation in their cellular signaling pathways influences brain function and alters behavioral performance. Multifunctional trophic factors such as VEGF and EPO that possess both neurotrophic and angiogenic actions are of particular interest due to their ability to rescue structural and plasticity deficits in neurons and vasculature. Obtaining insight into the behavioral, cellular and molecular actions of multi-functional trophic factors has the potential to open new and transformative therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475069      PMCID: PMC3951730          DOI: 10.1007/s00018-013-1281-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  145 in total

1.  Vascular niche for adult hippocampal neurogenesis.

Authors:  T D Palmer; A R Willhoite; F H Gage
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

2.  Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

Authors:  Greg J Siegle; Wesley Thompson; Cameron S Carter; Stuart R Steinhauer; Michael E Thase
Journal:  Biol Psychiatry       Date:  2006-10-06       Impact factor: 13.382

3.  Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression.

Authors:  Merja Viikki; Sami Anttila; Olli Kampman; Ari Illi; Martti Huuhka; Eija Setälä-Soikkeli; Nina Mononen; Terho Lehtimäki; Esa Leinonen
Journal:  Neurosci Lett       Date:  2010-04-24       Impact factor: 3.046

Review 4.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

Review 5.  Cerebrovascular diseases and depression.

Authors:  Himani Ghoge; Santvana Sharma; Shamash Sonawalla; Rajesh Parikh
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

6.  Cerebral perfusion response to successful treatment of depression with different serotoninergic agents.

Authors:  Andrei Vlassenko; Yvette I Sheline; Keith Fischer; Mark A Mintun
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

Review 7.  Vascular factors and depression.

Authors:  Emma Teper; John T O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2008-10       Impact factor: 3.485

8.  Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.

Authors:  J N Nicoletti; S K Shah; D P McCloskey; J H Goodman; A Elkady; H Atassi; D Hylton; J S Rudge; H E Scharfman; S D Croll
Journal:  Neuroscience       Date:  2007-10-26       Impact factor: 3.590

9.  Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

Authors:  Abner Louissaint; Sudha Rao; Caroline Leventhal; Steven A Goldman
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

10.  Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.

Authors:  Joshua Greene; Mounira Banasr; Boyoung Lee; Jennifer Warner-Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2009-06-24       Impact factor: 7.853

View more
  17 in total

Review 1.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 2.  Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.

Authors:  Ajaykumar N Sharma; Bruno Fernando Borges da Costa e Silva; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  J Affect Disord       Date:  2016-03-02       Impact factor: 4.839

3.  Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation.

Authors:  Yue Zhang; Gina Hong; Kin Sing Stephen Lee; Bruce D Hammock; Debebe Gebremedhin; David R Harder; Raymond C Koehler; Adam Sapirstein
Journal:  J Neurochem       Date:  2017-01-23       Impact factor: 5.372

4.  Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice.

Authors:  Dayalan Sampath; Joshua McWhirt; Monica Sathyanesan; Samuel S Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-08-24       Impact factor: 5.067

5.  Alterations in VEGF expression induced by antidepressant drugs in female rats under chronic social stress.

Authors:  Marta Maria Nowacka-Chmielewska; Monika Paul-Samojedny; Anna Maria Bielecka-Wajdman; Jarosław Jerzy Barski; Ewa Obuchowicz
Journal:  Exp Ther Med       Date:  2017-01-02       Impact factor: 2.447

6.  Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain.

Authors:  Zhuang Peng; Sha Peng; Kangguang Lin; Bin Zhao; Lai Wei; Qinhui Tuo; Duanfang Liao; Tifei Yuan; Zhe Shi
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

7.  The power of VEGF (vascular endothelial growth factor) family molecules.

Authors:  Jean-Leon Thomas; Anne Eichmann
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

8.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

9.  Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR.

Authors:  Evangelia S Panagiotou; Carla Sanjurjo Soriano; James A Poulter; Emma C Lord; Denisa Dzulova; Hiroyuki Kondo; Atsushi Hiyoshi; Brian Hon-Yin Chung; Yoyo Wing-Yiu Chu; Connie H Y Lai; Mark E Tafoya; Dyah Karjosukarso; Rob W J Collin; Joanne Topping; Louise M Downey; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

Review 10.  Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications.

Authors:  M Angela Cenci
Journal:  Front Neurol       Date:  2014-12-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.